SCHEMBL14484752

SCHEMBL14484752

COc1ccc(Oc2c(I)cc(CC(=O)O)cc2I)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 7/20 0.68
THRB P10828 7/20 0.68
PPARG P37231 3/20 0.68
RXRA P19793 2/20 0.68
ITGB3 P05106 1/20 0.68
ITGAV P06756 1/20 0.68
PCNA P12004 9/20 0.68
POLB P06746 3/20 0.68
HIF1A Q16665 2/20 0.68
HSD17B10 Q99714 2/20 0.68
ABCB11 O95342 1/20 0.68
LMNA P02545 1/20 0.68
CYP1A2 P05177 1/20 0.68
PGR P06401 1/20 0.68
CHRM2 P08172 1/20 0.68
HTR1A P08908 1/20 0.68
ADRA2A P08913 1/20 0.68
ADORA3 P0DMS8 1/20 0.68
AR P10275 1/20 0.68
CYP2C9 P11712 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4428790 0.88 THRB (0.52) THRATHRBPPARGRXRAITGB3
SCHEMBL5742498 0.87 PCNA (0.53) THRATHRBPPARGRXRAITGB3
SCHEMBL5742613 0.86 PCNA (0.74) THRATHRBPPARGRXRAITGB3
SCHEMBL14485308 0.85 PCNA (0.77) THRATHRBPPARGRXRAITGB3
SCHEMBL5742010 0.84 PCNA (0.57) THRATHRBPPARGRXRAITGB3
SCHEMBL6859639 0.83 PCNA (0.50) THRATHRBPPARGRXRAITGB3
SCHEMBL5859452 0.82 THRB (0.62) THRATHRBPPARGPTGS1AKR1C3
Tetrac SCHEMBL365951 0.81 THRB (1.00) THRATHRBPPARGRXRAITGB3
SCHEMBL6535223 0.81 PCNA (0.49) THRATHRBPPARGRXRAITGB3
Tiratricol SCHEMBL30161572 0.81 THRB (1.00) THRATHRBPPARGRXRAITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 US disclosed
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 US disclosed
WO-2013006734-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2013-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF THRA 3069/4885THRB 2853/4885PPARG 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.